PNH

Apr 16, 2024

Roche’s Columvi Phase III STARGLO Trial; Novartis’ Fabhalta Latest Data; Vertex’s Alpine Immune Sciences Acquisition; Telix Pharmaceuticals’ TLX101-CDx Fast Track Designation; NovelMed’s NM5072 Orphan Drug Designation

Feb 16, 2024

Will Roche’s Crovalimab An Answer to AstraZeneca PNH Treatment Drugs?

Jan 26, 2024

AstraZeneca Strengthens Presence in PNH Treatment with Voydeya in Japan: World’s First Approval

May 18, 2021

InnoCare’s Trial In China; Sanofi/GSK COVID-19 Vaccine; Apellis’s Empaveli for PNH; LianBio, Landos Collab

Newsletter/Whitepaper